BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 9548959)

  • 1. Alpha 1-adrenergic receptor subtype determinants for 4-piperidyl oxazole antagonists.
    Hamaguchi N; True TA; Goetz AS; Stouffer MJ; Lybrand TP; Jeffs PW
    Biochemistry; 1998 Apr; 37(16):5730-7. PubMed ID: 9548959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phenylalanine in the second membrane-spanning domain of alpha 1A-adrenergic receptor determines subtype selectivity of dihydropyridine antagonists.
    Hamaguchi N; True TA; Saussy DL; Jeffs PW
    Biochemistry; 1996 Nov; 35(45):14312-7. PubMed ID: 8916917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of critical extracellular loop residues involved in alpha 1-adrenergic receptor subtype-selective antagonist binding.
    Zhao MM; Hwa J; Perez DM
    Mol Pharmacol; 1996 Nov; 50(5):1118-26. PubMed ID: 8913343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An investigation of the uroselective properties of four novel alpha(1a)-adrenergic receptor subtype-selective antagonists.
    Pulito VL; Li X; Varga SS; Mulcahy LS; Clark KS; Halbert SA; Reitz AB; Murray WV; Jolliffe LK
    J Pharmacol Exp Ther; 2000 Jul; 294(1):224-9. PubMed ID: 10871316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-affinity studies for a novel series of homochiral naphtho and tetrahydronaphtho analogues of alpha 1 antagonist WB-4101.
    Bolchi C; Catalano P; Fumagalli L; Gobbi M; Pallavicini M; Pedretti A; Villa L; Vistoli G; Valoti E
    Bioorg Med Chem; 2004 Sep; 12(18):4937-51. PubMed ID: 15336273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. (Arylpiperazinyl)cyclohexylsufonamides: discovery of alpha(1a/1d)-selective adrenergic receptor antagonists for the treatment of Benign Prostatic Hyperplasia/Lower Urinary Tract Symptoms (BPH/LUTS).
    Chiu G; Li S; Connolly PJ; Pulito V; Liu J; Middleton SA
    Bioorg Med Chem Lett; 2007 Jun; 17(12):3292-7. PubMed ID: 17452102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective pharmacophore design for alpha1-adrenoceptor subtypes.
    MacDougall IJ; Griffith R
    J Mol Graph Model; 2006 Sep; 25(1):146-57. PubMed ID: 16406718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 1,3-dioxolane-based ligands as a novel class of alpha1-adrenoceptor antagonists.
    Brasili L; Sorbi C; Franchini S; Manicardi M; Angeli P; Marucci G; Leonardi A; Poggesi E
    J Med Chem; 2003 Apr; 46(8):1504-11. PubMed ID: 12672251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 1,2,4-Benzothiadiazine derivatives as alpha1 and 5-HT1A receptor ligands.
    Tait A; Luppi A; Franchini S; Preziosi E; Parenti C; Buccioni M; Marucci G; Leonardi A; Poggesi E; Brasili L
    Bioorg Med Chem Lett; 2005 Feb; 15(4):1185-8. PubMed ID: 15686938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure-activity relationships in 1,4-benzodioxan-related compounds. 6. Role of the dioxane unit on selectivity for alpha(1)-adrenoreceptor subtypes.
    Quaglia W; Pigini M; Piergentili A; Giannella M; Marucci G; Poggesi E; Leonardi A; Melchiorre C
    J Med Chem; 1999 Jul; 42(15):2961-8. PubMed ID: 10425105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative imaging in live human cells reveals intracellular alpha(1)-adrenoceptor ligand-binding sites.
    Mackenzie JF; Daly CJ; Pediani JD; McGrath JC
    J Pharmacol Exp Ther; 2000 Aug; 294(2):434-43. PubMed ID: 10900216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. (Phenylpiperidinyl)cyclohexylsulfonamides: development of alpha1a/1d-selective adrenergic receptor antagonists for the treatment of benign prostatic hyperplasia/lower urinary tract symptoms (BPH/LUTS).
    Chiu G; Li S; Connolly PJ; Pulito V; Liu J; Middleton SA
    Bioorg Med Chem Lett; 2007 Jul; 17(14):3930-4. PubMed ID: 17517507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New pyrimido[5,4-b]indoles as ligands for alpha(1)-adrenoceptor subtypes.
    Romeo G; Materia L; Manetti F; Cagnotto A; Mennini T; Nicoletti F; Botta M; Russo F; Minneman KP
    J Med Chem; 2003 Jul; 46(14):2877-94. PubMed ID: 12825930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonconserved residues in the second transmembrane-spanning domain of the D(4) dopamine receptor are molecular determinants of D(4)-selective pharmacology.
    Schetz JA; Benjamin PS; Sibley DR
    Mol Pharmacol; 2000 Jan; 57(1):144-52. PubMed ID: 10617689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 1,3-Dioxolane-based ligands as rigid analogues of naftopidil: structure-affinity/activity relationships at alpha1 and 5-HT1A receptors.
    Sorbi C; Franchini S; Tait A; Prandi A; Gallesi R; Angeli P; Marucci G; Pirona L; Poggesi E; Brasili L
    ChemMedChem; 2009 Mar; 4(3):393-9. PubMed ID: 19152363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological characterization and cross talk of alpha1a- and alpha1b-adrenoceptors coexpressed in human embryonic kidney 293 cells.
    Israilova M; Tanaka T; Suzuki F; Morishima S; Muramatsu I
    J Pharmacol Exp Ther; 2004 Apr; 309(1):259-66. PubMed ID: 14722320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 8-NH2-boldine, an antagonist of alpha1A and alpha1B adrenoceptors without affinity for the alpha1D subtype: structural requirements for aporphines at alpha1-adrenoceptor subtypes.
    Ivorra MD; Valiente M; Martínez S; Madrero Y; Noguera MA; Cassels BK; Sobarzo EM; D'Ocon P
    Planta Med; 2005 Oct; 71(10):897-903. PubMed ID: 16254819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Computer modeling of size and shape descriptors of alpha 1-adrenergic receptor antagonists and quantitative structure-affinity/selectivity relationships.
    Montorsi M; Menziani MC; Cocchi M; Fanelli F; De Benedetti PG
    Methods; 1998 Mar; 14(3):239-54. PubMed ID: 9571081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alpha(1) adrenoceptor subtype selectivity. 3D-QSAR models for a new class of alpha(1) adrenoceptor antagonists derived from the novel antipsychotic sertindole.
    Balle T; Andersen K; Søby KK; Liljefors T
    J Mol Graph Model; 2003 Jun; 21(6):523-34. PubMed ID: 12676239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. (Phenylpiperazinyl)cyclohexylureas: discovery of alpha1a/1d-selective adrenergic receptor antagonists for the treatment of benign prostatic hyperplasia/lower urinary tract symptoms (BPH/LUTS).
    Chiu G; Li S; Connolly PJ; Pulito V; Liu J; Middleton SA
    Bioorg Med Chem Lett; 2008 Jan; 18(2):640-4. PubMed ID: 18055202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.